Asprosin is known to change the antioxidant-oxidant balance by causing hyperinsulinemia and insulin resistance, thereby increasing the expression level of insulin-like growth factor 1 (IGF-1) [16,17], which causes cancer formation and metastasis [18]. Here, IGF1 is linked to Hyperinsulinemia.